treatment of osteoporosis articles & resources on Made-in-China.com

All Persons Taking Strontium Supplements Are Warned

Jan 19, 2014

All persons taking strontium supplements are warned that significant risks have been identified. Strontium drugs are not approved for treatment of osteoporosis in the United States. Now, the Risk Assessment Committee of the European ...

Tags: Health, Medicine

Romosozumab Is an Investigational Medicine in Phase 3 Clinical Development

Jan 3, 2014

Amgen (NASDAQ: AMGN) and UCB (Euronext Brussels:UCB) today announced results from a Phase 2 trial evaluating romosozumab (AMG 785/CDP7851) in postmenopausal women with low bone mineral density (BMD). Published in the New England Journal of ...

Tags: Amgen, UCB, Phase 2 trial evaluating romosozumab, postmenopausal women

Daiichi Sankyo Company Has Launched Pralia Subcutaneous Injection 60mg Syringe

Jun 13, 2013

Daiichi Sankyo Company has launched Pralia subcutaneous injection 60mg syringe (generic name denosumab) for the treatment of osteoporosis, following its manufacturing and marketing approval in Japan. Designed to specifically inhibit an ...

Tags: Daiichi Sankyo, Syringe

Azelon Has Completed a Phase 2A Trial Comparing Nasal Spray ZT-034

Nov 28, 2012

Azelon Pharmaceuticals has completed a phase 2a trial comparing nasal spray ZT-034 to Forteo administered by subcutaneous injection and placebo in women with low bone mass. Patients in the phase 2 study, which saw the enrollment of 130 ...

Tags: Azelon Pharmaceuticals, low bone mass, bone formation

Teva UK Has Announced The Launch of Generic Ibandronic Acid 150mg Film-Coated Tablets

Nov 28, 2012

Teva UK, a part of Teva Pharmaceutical Industries, has announced the launch of generic Ibandronic Acid 150mg film-coated tablets. Ibandronic Acid is a generic version of Bonviva (Ibandronic Acid) from Roche. The product is indicated for ...

Tags: Generic Bonviva, Ibandronic Acid, treatment of osteoporosis

EffRx Has Launched a New Effervescent Buffered Oral Solution for Osteoporosis Treatment

Nov 28, 2012

EffRx Pharmaceuticals has launched a new effervescent buffered oral solution (70mg), designed for the treatment of osteoporosis, in the US. The new solution, BINOSTO (alendronate sodium), is intended for the treatment of osteoporosis in ...

Tags: oral solution, osteoporosis, alendronate sodium